Pulmonx Corp [LUNG] stock is trading at $2.78, up 2.21%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The LUNG shares have gain 7.34% over the last week, with a monthly amount drifted -12.58%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pulmonx Corp [NASDAQ: LUNG] stock has seen the most recent analyst activity on March 10, 2025, when D. Boral Capital initiated its Buy rating and assigned the stock a price target of $17. Previously, Citigroup downgraded its rating to Neutral on December 11, 2024, and dropped its price target to $7.50. On June 04, 2024, Lake Street initiated with a Buy rating and assigned a price target of $12 on the stock. Wells Fargo downgraded its rating to a Equal Weight and decreased its price target to $14 on February 23, 2024. Craig Hallum initiated its recommendation with a Buy and recommended $18 as its price target on September 05, 2023. Wells Fargo upgraded its rating to Overweight for this stock on February 27, 2023, and upped its price target to $15. In a note dated January 03, 2023, BofA Securities downgraded an Underperform rating on this stock but restated the target price of $8.
Pulmonx Corp [LUNG] stock has fluctuated between $2.50 and $9.37 over the past year. Currently, Wall Street analysts expect the stock to reach $11.93 within the next 12 months. Pulmonx Corp [NASDAQ: LUNG] shares were valued at $2.78 at the most recent close of the market. An investor can expect a potential return of 329.14% based on the average LUNG price forecast.
Analyzing the LUNG fundamentals
Pulmonx Corp [NASDAQ:LUNG] reported sales of 87.47M for the trailing twelve months, which represents a growth of 19.54%. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at -0.66%, Pretax Profit Margin comes in at -0.65%, and Net Profit Margin reading is -0.65%. To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -0.64 and Total Capital is -0.46. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.73.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.72 points at the first support level, and at 2.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.86, and for the 2nd resistance point, it is at 2.93.
Ratios To Look Out For
For context, Pulmonx Corp’s Current Ratio is 4.97. Further, the Quick Ratio stands at 4.29, while the Cash Ratio is 2.99. Considering the valuation of this stock, the price to sales ratio is 1.28, the price to book ratio is 1.44.
Transactions by insiders
Recent insider trading involved Ferrari Richard, Director, that happened on Jun 12 ’25 when 8000.0 shares were sold. Director, Ferrari Richard completed a deal on Jun 13 ’25 to buy 5438.0 shares. Meanwhile, Director RICH FERRARI bought 8000.0 shares on Jun 12 ’25.
